Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
RESEARCH TOOLSreports
Holding ERNA?
Track your performance easily
ERNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.52 - $2.63
Previous Close$0.53
Volume116.17K
Average Volume (3M)70.81K
Market Cap
$27.34M
Enterprise Value$56.59M
Total Cash (Recent Filing)$4.30M
Total Debt (Recent Filing)$33.55M
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Apr 14, 2023EPS Estimate
-$2.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.31
Shares Outstanding51,374,713
10 Day Avg. Volume225,600
30 Day Avg. Volume70,812
Standard Deviation1.64
R-Squared0.02
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)-0.70
Price to Sales (P/S)62.77
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue98.08
Enterprise Value/Gross Profit-336.84
Enterprise Value/Ebitda-3.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eterna Therapeutics News
PremiumCompany Announcements
Eterna Therapeutics Strikes Key Deal for Disease-Fighting Tech
Ownership Overview
52.26% Insiders
0.09% Mutual Funds
0.52% Other Institutional Investors
47.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ERNA FAQ
What was Eterna Therapeutics’s price range in the past 12 months?
Eterna Therapeutics lowest stock price was $0.52 and its highest was $2.63 in the past 12 months.
What is Eterna Therapeutics’s market cap?
Currently, no data Available
When is Eterna Therapeutics’s upcoming earnings report date?
Eterna Therapeutics’s upcoming earnings report date is Apr 14, 2023 which is 589 days ago.
How were Eterna Therapeutics’s earnings last quarter?
Eterna Therapeutics released its earnings results on Nov 08, 2022. The company reported -$2.488 earnings per share for the quarter, missing the consensus estimate of -$2.2 by -$0.288.
Is Eterna Therapeutics overvalued?
According to Wall Street analysts Eterna Therapeutics’s price is currently Overvalued.
Does Eterna Therapeutics pay dividends?
Eterna Therapeutics does not currently pay dividends.
What is Eterna Therapeutics’s EPS estimate?
Eterna Therapeutics’s EPS estimate is -$2.4.
How many shares outstanding does Eterna Therapeutics have?
Eterna Therapeutics has 51,374,714 shares outstanding.
What happened to Eterna Therapeutics’s price movement after its last earnings report?
Eterna Therapeutics reported an EPS of -$2.488 in its last earnings report, missing expectations of -$2.2. Following the earnings report the stock price went up 3.67%.
Which hedge fund is a major shareholder of Eterna Therapeutics?
Currently, no hedge funds are holding shares in ERNA
---
Eterna Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.47%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-85.23%
Trailing 12-Months
Company Description
Eterna Therapeutics
NTN Buzztime, Inc. engages in the provision of entertainment and innovative technology services. It offers entertainment, live events, dining, marketing, hardware, and pricing products. It also includes performance analytics and secure payment with Europay, MasterCard, and Visa chip readers or with near-field communication (NFC) technology to accept Apple, Android, and Samsung Pay. The company was founded in 1984 and is headquartered in Carlsbad, CA.
---
Technical Analysis
---